Case Report
Copyright ©The Author(s) 2024.
World J Clin Oncol. Oct 24, 2024; 15(10): 1324-1332
Published online Oct 24, 2024. doi: 10.5306/wjco.v15.i10.1324
Figure 1
Figure 1 Computed tomography imaging. A: Computed tomography (CT) image prior to treatment; B: CT image following initial chemotherapy session, showing a reduction in the lesions.
Figure 2
Figure 2 Pathological examination microscopy images revealed medium-sized tumor cells with irregular nuclei and frequent mitotic figures. A: Hematoxylin-eosin staining at × 200 magnification; B: Hematoxylin-eosin staining at × 400 magnification.
Figure 3
Figure 3 Immunohistochemical staining of cervical myeloid sarcoma. A: Myeloperoxidase (70% +); B: Cluster of differentiation (CD) 43 (100% +); C: Ki-67 (50% +); D: CD34 (-).